M Jesus Martinez de Osaba
Overview
Explore the profile of M Jesus Martinez de Osaba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peris P, Martinez-Ferrer A, Monegal A, Martinez de Osaba M, Muxi A, Guanabens N
Bone
. 2012 Apr;
51(1):54-8.
PMID: 22487299
Unlabelled: It remains unclear whether vitamin D sufficiency optimizes response to bisphosphonate (BP) treatment in postmenopausal osteoporosis. We evaluated the role and possible mechanisms of vitamin D in adequate response...
2.
Enjuanes A, Ruiz-Gaspa S, Peris P, Ozalla D, Alvarez L, Combalia A, et al.
Endocrine
. 2010 Oct;
37(1):180-6.
PMID: 20963568
Alendronate is a well-established treatment for osteoporosis and suppresses bone resorption by a direct effect on osteoclasts and their precursors. The effect of alendronate on osteoclasts is produced, at least...
3.
Enjuanes A, Ruiz-Gaspa S, Peris P, Ozalla D, Alvarez L, Combalia A, et al.
Endocrine
. 2010 Oct;
37(2):322-8.
PMID: 20960270
Alendronate is a well-established treatment for osteoporosis and suppresses bone resorption by a direct effect on osteoclasts and their precursors. The effect of alendronate on osteoclasts is produced, at least...
4.
Gomez-Gil E, Navines R, Martinez de Osaba M, Diaz-Ricart M, Escolar G, Salamero M, et al.
Psychoneuroendocrinology
. 2009 Sep;
35(4):481-9.
PMID: 19762159
Introduction: The serotonin-1A (5-HT1A) receptor subtypes are considered as targets of a variety of antidepressant drugs. Previous studies have suggested different adaptive changes in pre- and post-synaptic 5-HT receptors in...
5.
Guanabens N, Enjuanes A, Alvarez L, Peris P, Caballeria L, Martinez de Osaba M, et al.
J Bone Miner Metab
. 2009 Feb;
27(3):347-54.
PMID: 19229472
The influence of osteoprotegerin and RANKL as regulators of osteoclastogenesis and bone remodeling in liver disease and in the development of osteoporosis in primary biliary cirrhosis (PBC) is uncertain. Therefore,...
6.
Guanabens N, Pares A, Ros I, Alvarez L, Pons F, Caballeria L, et al.
Am J Gastroenterol
. 2003 Oct;
98(10):2268-74.
PMID: 14572578
Objectives: Osteopenia increases the morbidity of primary biliary cirrhosis (PBC). In this study, we have compared two bisphosphonates, alendronate and cyclical etidronate, that inhibit osteoclast-mediated bone resorption and have examined...